Switch to:
More From Other Websites
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss Aug 23 2016
The $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation Aug 22 2016
Biotech's next big deal? Aug 22 2016
Betting on BioMarin Aug 22 2016
Biotechs Rise on Bet Medivation Losers Will Look to Next Deal Aug 22 2016
Biotech stocks rally as investors bet on the next big tie-up Aug 22 2016
BioMarin (BMRN) Stock Surges on Takeover Speculation Aug 22 2016
Break Up Gilead Sciences? Not So Fast Aug 19 2016
Why You Shouldn't Bet Against BioMarin Pharmaceutical (BMRN) Stock Aug 16 2016
The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen Aug 12 2016
How to Play a Nasdaq Breakout Aug 12 2016
Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat Aug 11 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Aug 11 2016
BIOMARIN PHARMACEUTICAL INC Financials Aug 11 2016
ETF’s with exposure to BioMarin Pharmaceutical, Inc. : August 9, 2016 Aug 09 2016
BioMarin Announces Pricing of Public Offering of Common Stock Aug 09 2016
BioMarin Announces Pricing of Public Offering of Common Stock Aug 09 2016
BioMarin (BMRN) Stock Tumbles in After-Hours Trading on Public Offering Aug 08 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK